East Brunswick, NJ, United States of America

Arthur McFadden


Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1983-1988

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Arthur McFadden

Introduction

Arthur McFadden is a notable inventor based in East Brunswick, NJ, recognized for his contributions to the field of pharmaceuticals with a particular focus on analgesic and anti-inflammatory compounds. With a total of four patents to his name, McFadden has shown a keen ability to innovate, creating compounds that could enhance medical treatments.

Latest Patents

Among his latest work, McFadden has patented various compounds, including the 1-substituted, 2,3-diphenyl-3-hydroxymethyl pyrrolidines, which involve structures that have shown potential as effective analgesic and anti-inflammatory agents. These compounds exhibit the general formula that involves substituents capable of delivering therapeutic benefits. This latest work demonstrates his commitment to advancing medical science through innovative chemistry.

Career Highlights

Arthur McFadden is affiliated with The Purdue Frederick Company, where he has utilized his expertise to develop impactful medical solutions. His career has been marked by a passion for research and development in the pharmaceutical sector, allowing him to carve out a significant niche in the industry.

Collaborations

During his tenure, McFadden has collaborated with various talented individuals, including colleagues Bola V. Shetty and Peter Hofer. These partnerships have likely contributed to the success of his innovations, showcasing the importance of teamwork in advancing research projects.

Conclusion

Arthur McFadden's journey in innovation reflects a dedication to improving health outcomes through his inventive spirit. With numerous patents and collaborations under his belt, he continues to be a valuable player in the pharmaceutical industry, driving forward the development of new and effective therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…